Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings

Closed Posted

Opportunity number
RFA-PS-23-004
Agency
Applications due
Award size
$750,000 to $1,000,000

Opportunity facts

Assistance listings
Funding instrument
Cooperative Agreement
Category
  • Health
Eligible applicants
  • Special District Governments
  • Small Businesses
  • Independent School Districts
  • County Governments
  • Higher Education Inst. (Public)
  • State Governments
  • Tribal Organizations (Not Federally Recognized)
  • City/Township Governments
  • Public or Indian Housing Auth.
  • 501(c)(3) Nonprofits
  • For Profit Organizations
  • Higher Education Inst. (Private)
  • Non-501(c)(3) Nonprofits
  • Tribal Governments (Federally Recognized)

Opportunity details come from Grants.gov. Updated .

Synopsis

The purpose of this notice of funding opportunity is to support research on Long-Acting Injectable-Antiretroviral Therapy (LAI-ART) by implementing LAI-ART administration in both clinic and non-clinic settings (e.g., community pharmacies). A multi-site effectiveness-implementation research study designed to compare receiving LAI-ART in clinic or pharmacy settings with the oral standard-of-care for the treatment of HIV will offer a unique source of information for improving acceptability, availability, and uptake of LAI-ART. Implementation outcomes of interest include acceptability, perceived barriers and facilitators, feasibility, and sustainability. Health outcomes of interest include missed visits, on-time receipt of injections, and the HIV care continuum, including retention in care and viral load suppression. The data collected will describe real-world LAI-ART use among persons with HIV (PWH) in an era of multiple HIV treatment modalities. Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity